hydralazine has been researched along with alprostadil in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Priebe, HJ | 2 |
Pearl, RG; Siegel, LC | 1 |
Hsueh, W; Zhang, C | 1 |
Kono, M; Morita, S; Ozawa, M; Sato, T; Takahashi, H; Uno, Y | 1 |
McLean, RF; Pearl, RG; Prielipp, RC; Rosenthal, MH | 1 |
Delcroix, M; Leeman, M; Lejeune, P; Mélot, C; Naeije, R | 1 |
Friedman, WF; George, BL | 1 |
Pearl, RG; Prielipp, RC; Rosenthal, MH | 1 |
Goldberg, HS; Halpern, SM; Jasper, AC; Koerner, SK; Lehrman, S; Shah, PK | 1 |
Hedley, LR; Strosberg, AM; Van Antwerp, DR | 1 |
Fujihara, H; Fujiwara, N; Fukuda, S; Sakuma, K; Shimoji, K; Tanaka, T; Toriumi, T; Tsukui, A | 1 |
Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
Demir, B; Engin, MS; Keleş, MK; Küçüker, İ; Yosma, E | 1 |
17 other study(ies) available for hydralazine and alprostadil
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Topics: Alprostadil; Animals; Coronary Disease; Coronary Vessels; Dogs; Hemodynamics; Hydralazine; Hypertension, Pulmonary; Models, Cardiovascular; Nitroglycerin; Pulmonary Gas Exchange; Respiration | 1992 |
Effects of prostaglandin E1 and hydralazine on the longitudinal distribution of pulmonary vascular resistance during vasoconstrictor pulmonary hypertension in sheep.
Topics: Alprostadil; Animals; Hydralazine; Hypertension, Pulmonary; Lung; Male; Prostaglandin Endoperoxides, Synthetic; Random Allocation; Sheep; Vascular Resistance; Vasodilation | 1992 |
PAF-induced bowel necrosis. Effects of vasodilators.
Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents | 1991 |
Effects of hydralazine and prostaglandin E1 on regional myocardial function in the ischemic canine heart.
Topics: Alprostadil; Animals; Coronary Circulation; Coronary Disease; Dogs; Female; Hydralazine; Male; Regional Blood Flow | 1991 |
Vasodilator therapy in microembolic porcine pulmonary hypertension.
Topics: Alprostadil; Animals; Ferricyanides; Hemodynamics; Hydralazine; Hypertension, Pulmonary; Infusions, Intravenous; Male; Models, Biological; Nitroglycerin; Nitroprusside; Prostaglandins E; Pulmonary Embolism; Swine; Vasodilation | 1990 |
Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
Topics: Acute Disease; Alprostadil; Animals; Dogs; Hydralazine; Hypertension, Pulmonary; Nitroprusside; Pulmonary Embolism; Pulmonary Gas Exchange; Vasodilator Agents | 1990 |
Treatment of cardiac failure in infants.
Topics: Alprostadil; Captopril; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Indomethacin; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside | 1986 |
Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Disease Models, Animal; Hydralazine; Hypertension, Pulmonary; Nitroglycerin; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Sheep; Vasodilator Agents | 1988 |
Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
Topics: Alprostadil; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Heart Ventricles; Hemodynamics; Hydralazine; Hypertension, Pulmonary; Lung; Male; Nitroglycerin; Pulmonary Embolism; Pulmonary Gas Exchange; Vasodilator Agents | 1988 |
Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
Topics: Adult; Aged; Alprostadil; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Oxygen; Pulmonary Circulation; Pulmonary Gas Exchange; Vasodilator Agents | 1987 |
Differences in blood pressure lowering effects in PGs following indirect and direct blood pressure measurements.
Topics: Alprostadil; Animals; Blood Pressure; Blood Pressure Determination; Dinoprostone; Hydralazine; Male; Prazosin; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred SHR | 1984 |
Hypoxia modifies the vasodilatory effects of nitroglycerin, prostaglandin E1, and hydralazine on isolated porcine coronary arteries.
Topics: Alprostadil; Analysis of Variance; Animals; Coronary Vessels; Cyclic AMP; Cyclic GMP; Endothelins; Hydralazine; Hypoxia; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Swine | 1994 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |
Comparison of the effects of different vasoactive and antiplatelet drugs on perforator flap viability. An experimental study.
Topics: Alprostadil; Animals; Arteries; Epigastric Arteries; Graft Survival; Hydralazine; Nifedipine; Perforator Flap; Piracetam; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2016 |